{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T03:59:35Z","timestamp":1649217575261},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8,2]]},"DOI":"10.1093\/jnci\/djj340","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T18:06:19Z","timestamp":1154541979000},"page":"1028-1030","source":"Crossref","is-referenced-by-count":3,"title":["Ariad Pharmaceuticals Wins First Round Over Eli Lilly, Patents on Methods Can Be Far-reaching"],"prefix":"10.1093","volume":"98","author":[{"given":"George S.","family":"Mack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,8,2]]},"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/98\/15\/1028\/7687553\/djj340.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T01:27:56Z","timestamp":1507858076000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jnci\/article\/98\/15\/1028\/2521720\/Ariad-Pharmaceuticals-Wins-First-Round-Over-Eli"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,2]]},"references-count":0,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2006,8,2]]},"published-print":{"date-parts":[[2006,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djj340","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,8,2]]},"published":{"date-parts":[[2006,8,2]]}}}